HeraMED Ltd. (AU:HMD) has released an update.
HeraMED Ltd. has announced the offer of 67,500,000 options at $0.01 each, expiring three years from issuance, with the primary target market being Westar Capital Limited and/or its nominees. The options, which convert into ordinary shares, are part of a speculative investment strategy suitable for investors with a medium to long-term outlook and the financial capability to exercise the options before they expire. Potential investors are advised to consult the Prospectus for detailed information and to ensure they meet the target market criteria.
For further insights into AU:HMD stock, check out TipRanks’ Stock Analysis page.
